Jonathan Allan

General Counsel & Corp Sec, Stoke Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.3M

Companies

Latest trade

Oct 2, 2026

Companies

Stoke Therapeutics, Inc.General Counsel & Corp Sec −$1.6M

Trades

STOK Sold 627 shares at $26.33 · planned $0.0M Oct 2

STOK Sold 2,861 shares at $32.03 $0.1M Aug 18

STOK Sold 1,457 shares at $29.95 · planned $0.0M Jun 16

STOK Sold 9,293 shares at $33.69 · planned $0.3M Mar 20

STOK Sold 4,628 shares at $31.34 $0.1M Mar 18

STOK Sold 4,267 shares at $33.01 $0.1M Mar 17

STOK Sold 3,978 shares at $32.28 · planned $0.1M Dec 8

STOK Sold 8,785 shares at $31.29 · planned $0.3M Dec 5

STOK Sold 1,018 shares at $30.87 · planned $0.0M Dec 4

STOK Sold 2,292 shares at $30.65 $0.1M Dec 3

STOK Sold 2,284 shares at $29.78 $0.1M Dec 2

STOK Sold 10,000 shares at $25.07 · planned $0.3M Oct 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.